Lupin Ltd has launched the Ganirelix Acetate injection, a single-dose prefilled syringe approved by the US FDA, for women undergoing fertility treatments. The injection, a generic equivalent to Organon USA LLC, is used to inhibit premature Luteinizing Hormone surges. It has an estimated annual sales of USD 87 million in the US. Read The Rest at :
Disclaimer : Mymoneytimes implements extreme caution and care in collecting data before publication. Mymoneytimes does not liable for the adequacy, accuracy or completeness of any given information. Hence we are not liable for any kind of direct or indirect loss caused by the use of such information.
